Asian Fund for Cancer Research
Overview
Asian Fund for Cancer Research is a non-profit organization that provides investment funding to early-stage biotechnology companies to accelerate the development of innovative therapeutics, diagnostics, and cancer prevention products.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Acurion | Apr 2026 | Seed | Co-investor |
| Arbele Limited | Apr 2021 | Seed | Co-investor |
| Yiviva | Feb 2018 | Series A | Co-investor |
Key People
Kwok Wai Leung
Chief Financial Officer
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Asian Fund for Cancer Research based?
Asian Fund for Cancer Research is headquartered in Hong Kong.
When was Asian Fund for Cancer Research founded?
Asian Fund for Cancer Research was founded in 2005.
How many portfolio companies does Asian Fund for Cancer Research have?
Asian Fund for Cancer Research has 3 portfolio companies in Caplight's dataset.
What are some companies in Asian Fund for Cancer Research's portfolio?
Portfolio companies visible on Caplight include Acurion, Arbele Limited, Yiviva.
What was Asian Fund for Cancer Research's most recent investment shown here?
Asian Fund for Cancer Research's most recent investment in this portfolio sample was in Acurion in 2026.
What sectors does Asian Fund for Cancer Research focus on?
Asian Fund for Cancer Research focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does Asian Fund for Cancer Research focus on?
Asian Fund for Cancer Research typically invests at the Early stage.